Clinical Trials Directory

Trials / Completed

CompletedNCT04494620

Evaluating Oral Visual Inspection in the Control of Oral Cancer

Randomized Intervention Trial to Evaluate Oral Visual Inspection in the Control of Oral Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
191,873 (actual)
Sponsor
International Agency for Research on Cancer · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Accepted

Summary

Cluster-randomized controlled trial in Trivandrum district, Kerala, India to evaluate the effect of triennial screening for oral cavity cancer using visual inspection on oral cancer mortality.

Detailed description

The study population consisted of 13 administrative regions (clusters) in Trivandrum district, Kerala, southern Indian. 7 clusters were randomly assigned to the intervention arm (3 rounds of oral visual inspection conducted 3 years apart) and were compared to the remaining 6 clusters assigned to a control arm that received standard of care. The eligibility criteria were all healthy subjects aged 35 and older, without a personal history of oral cancer. Informed consent was signed by each participant. The intervention arm consisted of 96,517 participants and the control group consisted of 95,356 participants.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTVisual Inspection of Oral Cavity for Precancers and CancerParticipants were invited for 3 rounds of oral cavity cancer screening, conducted 3-years apart. Screening was conducted by health workers trained to perform visual inspection of the oral mucosa and identify potential precancerous lesions or oral cancer. Lesions found were referred to a weekly clinic for further evaluation by dentists and oncologists with experience in the diagnosis of oral lesions. Oral precancerous lesions were surgically excised whenever possible and those with confirmed oral cancer were referred for appropriate treatment with surgery, radiotherapy, and/or chemotherapy.

Timeline

Start date
1996-01-01
Primary completion
2004-12-31
Completion
2014-12-31
First posted
2020-07-31
Last updated
2020-07-31

Source: ClinicalTrials.gov record NCT04494620. Inclusion in this directory is not an endorsement.